GlassScriptPhysician profile
Prashanth Venkatesh
NPI 1629496781
$2,947.84
in general payments reported to CMS, 2019-2025
9 companies · $30.60 in 2025
The $30.60 reported for 2025 was less than what a typical Adult Congenital Heart Disease provider received nationally (typical 2025 total: $272).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.62 · 2022: $314 · 2023: $2,313 · 2024: $273 · 2025: $30.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449 · Travel and Lodging: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.12 |
| Travel and Lodging | $1,168.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,115.90 | 2021-2024 | Harmony |
| Abbott Laboratories | $356.82 | 2023-2024 | Amplatzer Piccolo |
| Actelion Pharmaceuticals US, INC. | $141.91 | 2023 | Uptravi, Opsumit |
| Esperion Therapeutics, INC. | $104.46 | 2023 | Nexletol, Nexlizet |
| Pfizer INC. | $95.94 | 2023 | |
| Heartflow, INC. | $39.74 | 2024 | |
| Lantheus Medical Imaging, INC. | $38.39 | 2023 | Definity |
| Ge Healthcare | $30.60 | 2025 | |
| Lilly USA, LLC | $24.08 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashanth Venkatesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.